Physician profile
Lida Zhen
NPI 1942256581
$2,597.09
in general payments reported to CMS, 2019-2025
19 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,451 · 2020: $163 · 2022: $120 · 2023: $91.33 · 2024: $403 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $368.81 | 2024-2025 | Voquezna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $291.60 | 2019 | |
| Braintree Laboratories, INC. | $205.99 | 2019 | |
| Ferring Pharmaceuticals INC. | $198.78 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $166.77 | 2019-2020 | |
| Abbott Laboratories | $156.24 | 2024 | Freestyle Libre 3 |
| Pfizer INC. | $138.32 | 2019-2020 | |
| Shionogi INC | $130.05 | 2019 | |
| Gilead Sciences, INC. | $126.49 | 2019 | |
| Intra-Sana Laboratories | $124.99 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Vanda Pharmaceuticals INC. | $121.91 | 2025 | Fanapt |
| Lundbeck LLC | $119.56 | 2022 | |
| Janssen Pharmaceuticals, INC | $105.40 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $91.33 | 2023 | Rexulti |
| Abbvie INC. | $87.97 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $56.12 | 2019 | |
| Intercept Pharmaceuticals, INC. | $52.73 | 2019 | |
| Shire North American Group INC | $38.55 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lida Zhen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.